how to assess whether CNW is offering the right services to be a sound investment: https://unauthorised investment adv...omputing-theres-plenty-potential-says-expert/
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling